Shanghai Pioneer Holding 1345.HK · HKD

Its shares trade on HKEX under the ticker 1345.HK. It has been listed since 5 November 2013. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.49bn and net income of CN¥133.2m. At that date it held total assets of CN¥1.74bn and shareholders' equity of CN¥1.22bn.

China Pioneer Pharma Holdings Ltd. is an investment holding company, which engages in the manufacture, promotion, and sale of pharmaceutical products. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2013-11-05. The firm operates through two business segments. The Ophthalmic Pharmaceutical Products segment is engaged in the sales of ophthalmic pharmaceutical products by provision of channel management services and co-promotion services. The Products Sold Via the Provision of Comprehensive Marketing, Promotion and Channel Management Services segment is engaged in the sales of all pharmaceutical products and medical devices except for ophthalmic pharmaceutical products. The firm is also engaged in the manufacturing of chemical and pharmaceutical products through its subsidiaries.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Xinzhou LiExecutive Chairman of the Board, since 2013CN¥1.0m
• Mr. Yi XueChief Financial Officer
• Mr. Yuewen YangChief Operating Officer, Executive Director, since 2019
• Ms. Wenfei HuangGeneral Manager - Ophthalmology Business Unit
• Ms. Rongrong WangGeneral Manager - Alcon Business Unit, National Director - Commerce Department
• Ms. Xiuyan YangGeneral Manager - Polichem Business Unit
• Mr. Quan ZhangExecutive Director, since 2023
• Mr. Tao WangBusiness Development Director
• Ms. Yue YuGovernment Affairs Director
• Ms. Ka Man NgCompany Secretary
• Ms. Mingfei HuNon-Executive DirectorCN¥212,000
• Mr. Chanshu LaiNon-Executive Independent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.